What are the recommended medications for rapid intubation in a patient with a suspected drug overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rapid Sequence Intubation Medications for Drug Overdose

For drug overdose patients requiring intubation, use etomidate (0.2-0.3 mg/kg) or ketamine (1-2 mg/kg) as the induction agent, followed immediately by either succinylcholine (1-1.5 mg/kg) or rocuronium (0.9-1.2 mg/kg) as the neuromuscular blocking agent, with the specific choice guided by hemodynamic stability and contraindications. 1, 2, 3

Patient Assessment and Preparation

Before medication administration, rapidly assess:

  • Hemodynamic status: Overdose patients frequently present with sympathetic exhaustion and occult hypovolemia that becomes unmasked after induction 4
  • Aspiration risk: All overdose patients should be considered "full stomach" and managed with RSI technique 1, 5
  • Cooperation level: Agitated or combative patients require medication-assisted preoxygenation before paralysis 2, 3

Position the patient in semi-Fowler position (head and torso inclined) to reduce aspiration risk and improve first-pass success 1, 2, 5

Preoxygenation Strategy

  • For cooperative patients: Use high-flow nasal oxygen (HFNO) or noninvasive positive pressure ventilation (NIPPV) for 3-5 minutes 1, 2
  • For agitated/combative patients: Administer ketamine 1-1.5 mg/kg IV for medication-assisted preoxygenation (delayed sequence intubation), which increases oxygen saturation by approximately 8.9% before administering the neuromuscular blocker 2, 3

Induction Agent Selection

Etomidate (Preferred for Hemodynamically Unstable Patients)

Dose: 0.2-0.3 mg/kg IV 1, 3

  • Provides minimal cardiovascular depression, making it ideal for overdose patients with sympathetic exhaustion 1, 3
  • Recent high-quality evidence shows no difference in mortality or hypotension compared to other agents 1
  • Rapid onset with short duration of action 3

Ketamine (Alternative, Especially for Agitated Patients)

Dose: 1-2 mg/kg IV 1, 3

  • Maintains respiratory drive and increases catecholamine release 3
  • Critical caveat: May cause paradoxical hypotension in critically ill overdose patients with depleted catecholamine stores 1, 3
  • Preferred for medication-assisted preoxygenation in uncooperative patients 2, 3

Avoid or Use with Extreme Caution

  • Propofol: Causes significant vasodilation and hypotension, particularly problematic in overdose patients 1, 4
  • Midazolam: Longer onset of action and potent venodilation at RSI doses 1

Neuromuscular Blocking Agent Selection

A neuromuscular blocking agent must always be administered when a sedative-hypnotic is used for intubation 1, 3

Succinylcholine (First-Line Choice)

Dose: 1-1.5 mg/kg IV 1, 2, 6

  • Rapid onset (30-60 seconds) with short duration (5-10 minutes) 1, 7
  • Allows faster return of spontaneous ventilation if intubation fails 1
  • Contraindications: Hyperkalemia, malignant hyperthermia history, neuromuscular disease, significant burns >24 hours old 7

Rocuronium (Alternative When Succinylcholine Contraindicated)

Dose: 0.9-1.2 mg/kg IV for RSI 1, 2, 6

  • Provides intubating conditions in approximately 1 minute at high doses 6
  • Duration of 58-67 minutes at RSI doses 6
  • Critical requirement: Sugammadex must be immediately available for reversal in "cannot intubate/cannot oxygenate" scenarios 1, 3, 5
  • Important pitfall: Longer duration may delay post-intubation analgosedation, potentially increasing awareness risk 1, 5

Evidence-Based Medication Algorithm

For hemodynamically stable overdose patients:

  • Etomidate 0.2-0.3 mg/kg + Succinylcholine 1-1.5 mg/kg 1, 3

For hemodynamically unstable overdose patients:

  • Etomidate 0.2-0.3 mg/kg (preferred) + Succinylcholine 1-1.5 mg/kg 1, 3

For agitated/uncooperative overdose patients:

  • Ketamine 1-1.5 mg/kg for preoxygenation, then after 3 minutes: Etomidate 0.2-0.3 mg/kg + Succinylcholine 1-1.5 mg/kg 2, 3

When succinylcholine is contraindicated:

  • Etomidate 0.2-0.3 mg/kg + Rocuronium 0.9-1.2 mg/kg (with sugammadex immediately available) 1, 3, 6

Critical Timing and Administration

  • Administer medications in rapid succession without delay 3, 5
  • Perform immediate endotracheal tube placement before assisted ventilation begins 3, 5
  • Do not administer additional doses of succinylcholine if initial intubation fails—proceed to rescue airway plan 1

Overdose-Specific Considerations

Recent evidence demonstrates that overdose patients have higher first-pass success without adverse events (85.0%) compared to other indications (78.7%), with significantly less hypotension (1.5% vs 4.1%) 8. However, this favorable profile depends on appropriate medication selection and technique.

Key risk factors for intubation in overdose patients include younger age and obstructive lung disease 9. Patients with obstructive lung disease have significantly more hypercapnia and acidemia, requiring particular attention to preoxygenation 9.

Common Pitfalls and How to Avoid Them

  • Inadequate preoxygenation in agitated patients: Use ketamine-based medication-assisted preoxygenation rather than attempting to force mask on combative patient 2, 3
  • Postintubation hypotension: Anticipate marked attenuation of sympathetic tone after resolving hypoxia/hypercarbia; have vasopressors immediately available 4
  • Failure to have sugammadex available when using rocuronium: This is mandatory for safe practice 1, 3, 5
  • Using propofol in hemodynamically unstable overdose patients: Choose etomidate instead 1, 3
  • Forgetting that all analgesics and sedatives can cause vasodilation and hypotension by abolishing sympathetic tone: Reduce standard doses and titrate to effect 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rapid Sequence Intubation in Emergency Situations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Sequence Intubation Pharmacology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Sequence Induction and Intubation in Anesthesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rapid-sequence intubation and the role of the emergency department pharmacist.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011

Related Questions

What medications are used for intubation and sedation maintenance in anesthesia?
What is the next step in management for a patient with deep vein thrombosis (DVT) and signs of hypotension, tachycardia, and hypoxia after a fluid bolus?
What is the next treatment step for an asthmatic patient with throat itching, chest tightness, shortness of breath, hypotension, tachycardia, tachypnea, stridor, and diminished breath sounds who is non-responsive to epinephrine (adrenaline)?
Can intubation directly aid in dyspnea (difficulty breathing) from myocardial infarction (heart attack)?
What is the agent used for rapid sequence intubation (RSI)?
What percentage of systemic lupus erythematosus (SLE) patients develop lupus nephritis?
What bloodwork is needed for a definitive diagnosis of lupus in a young to middle-aged woman, especially those from high-risk ethnic groups?
How soon can a patient with high risk for thromboembolic events and normal or impaired renal function be started on Lovenox (enoxaparin) after ureteral stent placement?
What are the management and treatment options for a patient with a split urethral meatus, considering their age, medical history, and symptoms?
What is the differential diagnosis and management approach for an adult patient, particularly those with a history of smoking or other cardiovascular risk factors, presenting with erythrocytosis (increased red blood cell mass)?
What is the recommended use of D5LR (5% dextrose in lactated Ringer's solution) in stroke patients, particularly those with a history of diabetes or hyperglycemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.